1)Murakoshi A, Takaesu Y, Komada Y, et al:Prevalence and associated factors of hypnotics dependence among Japanese outpatients with psychiatric disorders. Psychiatry Res 230:958-963, 2015
2)Stewart SA:The effects of benzodiazepines on cognition. J Clin Psychiatry 66(Suppl 2):9-13, 2005
3)Wang PS, Bohn RL, Glynn RJ:Hazardous benzodiazepine regimens in the elderly:effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 158:892-898, 2001
4)三島和夫(睡眠薬適正使用及び減量・中止のための診療ガイドラインに関する研究班)編:睡眠薬の適正使用・休薬ガイドライン.じほう,2014
5)Morin CM, Colecchi C, Stone J, et al:Behavioral and pharmacological therapies for late-life insomnia:a randomized controlled trial. JAMA 281:991-999, 1999
6)Qaseem A, Kansagara D, Forciea MA, et al:Clinical Guidelines Committee of the American College of P:Management of chronic insomnia disorder in adults:a clinical practice guideline from the American college of physicians. Ann Inter Med 165:125-133, 2016
7)三島和夫:厚生労働省障害者政策総合研究事業 精神科領域におけるより適切な向精神薬長期使用等の出口戦略の実践に資する研究(課題番号:19GC1201).平成30年-令和2年度
8)Elwyn G, O' Connor A, Stacey D, et al:Developing a quality criteria framework for patient decision aids:online international Delphi consensus process. BMJ 333:417, 2006
9)Joseph-Williams N, Newcombe R, Politi M, et al:Toward minimum standards for certifying patient decision aids:a modified delphi consensus process. Med Decis Making 34:699-710, 2014
10)Belleville G, Guay C, Guay B, et al:Hypnotic taper with or without self-help treatment of insomnia:a randomized clinical trial. J Consul Clin Psychol 75:325-335, 2007
11)Lichstein KL, Nau SD, Wilson NM, et al:Psychological treatment of hypnotic-dependent insomnia in a primarily older adult sample. Behav Res Ther 51:787-796, 2013
12)三島和夫:厚生労働省障害者政策総合研究事業 向精神薬の処方実態の解明と適正処方を実践するための薬物療法ガイドラインに関する研究(H29-精神-一般-001)分担・統括研究報告書.2017
13)Takaesu Y, Utsumi T, Okajima I, et al:Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia:a systematic review and meta-analysis. Sleep Med Rev 48:101214, 2019